Position in GH
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$900
New position
Shares Held
6
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#572
of 593 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026LRI Investments, LLC holds $6,589,239 across 23 Diagnostics & Research names. GH ranks #18 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
23,909 | $4,619,696 | |
| 2 | DHR |
Danaher Corp /De/
|
3,317 | $631,821 | |
| 3 | NTRA |
Natera, Inc.
|
1,596 | $433,234 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
757 | $379,529 | |
| 5 | DGX |
Quest Diagnostics Inc
|
1,026 | $217,460 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
186 | $98,503 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
146 | $76,859 | |
| 8 | WGS |
GeneDx Holdings Corp.
|
837 | $57,460 |
All Filings in GH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $900 | 6 | Shares | Sole | 2026-07-14 | |
| No filing history on record for this holder in this stock. | ||||||